1
|
Hua X, Li Y, Pentaparthi SR, McGrail DJ, Zou R, Guo L, Shrawat A, Cirillo KM, Li Q, Bhat A, Xu M, Qi D, Singh A, McGrath F, Andrews S, Aung KL, Das J, Zhou Y, Lodi A, Mills GB, Eckhardt SG, Mendillo ML, Tiziani S, Wu E, Huang JH, Sahni N, Yi SS. Landscape of MicroRNA Regulatory Network Architecture and Functional Rerouting in Cancer. Cancer Res 2023; 83:59-73. [PMID: 36265133 PMCID: PMC9811166 DOI: 10.1158/0008-5472.can-20-0371] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/03/2020] [Revised: 12/15/2020] [Accepted: 10/14/2022] [Indexed: 02/05/2023]
Abstract
Somatic mutations are a major source of cancer development, and many driver mutations have been identified in protein coding regions. However, the function of mutations located in miRNA and their target binding sites throughout the human genome remains largely unknown. Here, we built detailed cancer-specific miRNA regulatory networks across 30 cancer types to systematically analyze the effect of mutations in miRNAs and their target sites in 3' untranslated region (3' UTR), coding sequence (CDS), and 5' UTR regions. A total of 3,518,261 mutations from 9,819 samples were mapped to miRNA-gene interactions (mGI). Mutations in miRNAs showed a mutually exclusive pattern with mutations in their target genes in almost all cancer types. A linear regression method identified 148 candidate driver mutations that can significantly perturb miRNA regulatory networks. Driver mutations in 3'UTRs played their roles by altering RNA binding energy and the expression of target genes. Finally, mutated driver gene targets in 3' UTRs were significantly downregulated in cancer and functioned as tumor suppressors during cancer progression, suggesting potential miRNA candidates with significant clinical implications. A user-friendly, open-access web portal (mGI-map) was developed to facilitate further use of this data resource. Together, these results will facilitate novel noncoding biomarker identification and therapeutic drug design targeting the miRNA regulatory networks. SIGNIFICANCE A detailed miRNA-gene interaction map reveals extensive miRNA-mediated gene regulatory networks with mutation-induced perturbations across multiple cancers, serving as a resource for noncoding biomarker discovery and drug development.
Collapse
Affiliation(s)
- Xu Hua
- Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
| | - Yongsheng Li
- Livestrong Cancer Institutes, Department of Oncology, Dell Medical School, The University of Texas at Austin, Austin, TX 78712, USA
| | - Sairahul R. Pentaparthi
- Livestrong Cancer Institutes, Department of Oncology, Dell Medical School, The University of Texas at Austin, Austin, TX 78712, USA
| | - Daniel J. McGrail
- Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
| | - Raymond Zou
- Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX 77054, USA
| | - Li Guo
- Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
| | - Aditya Shrawat
- College of Natural Sciences, The University of Texas at Austin, Austin, TX 78712, USA
| | - Kara M. Cirillo
- Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX 77054, USA
| | - Qing Li
- Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX 77054, USA
| | - Akshay Bhat
- Livestrong Cancer Institutes, Department of Oncology, Dell Medical School, The University of Texas at Austin, Austin, TX 78712, USA
| | - Min Xu
- Neuroscience Institute and Department of Neurosurgery, Baylor Scott & White Health, Temple, TX 76502, USA
| | - Dan Qi
- Neuroscience Institute and Department of Neurosurgery, Baylor Scott & White Health, Temple, TX 76502, USA
| | - Ashok Singh
- Dell Medical School, The University of Texas at Austin, Austin, TX 78712, USA
| | - Francis McGrath
- Dell Medical School, The University of Texas at Austin, Austin, TX 78712, USA
| | - Steven Andrews
- Dell Medical School, The University of Texas at Austin, Austin, TX 78712, USA
| | - Kyaw Lwin Aung
- Livestrong Cancer Institutes, Department of Oncology, Dell Medical School, The University of Texas at Austin, Austin, TX 78712, USA
| | - Jishnu Das
- Center for Systems Immunology, Department of Immunology, and Department of Computational and Systems Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA
| | - Yunyun Zhou
- Raymond G. Perelman Center for Cellular and Molecular Therapeutics, Children’s Hospital of Philadelphia, Philadelphia, PA 19104, USA
| | - Alessia Lodi
- Department of Nutritional Sciences, College of Natural Sciences, The University of Texas at Austin, Austin, TX 78712, USA,Department of Pediatrics, Dell Medical School, The University of Texas at Austin, Austin, TX 78712, USA
| | - Gordon B. Mills
- Department of Cell, Developmental and Cancer Biology, School of Medicine, Oregon Health & Science University, Portland, OR 97201, USA,Precision Oncology, Knight Cancer Institute, Portland, OR 97201, USA
| | - S. Gail Eckhardt
- Livestrong Cancer Institutes, Department of Oncology, Dell Medical School, The University of Texas at Austin, Austin, TX 78712, USA,Interdisciplinary Life Sciences Graduate Programs (ILSGP), The University of Texas at Austin, Austin, TX 78712, USA
| | - Marc L. Mendillo
- Department of Biochemistry and Molecular Genetics, and Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA
| | - Stefano Tiziani
- Livestrong Cancer Institutes, Department of Oncology, Dell Medical School, The University of Texas at Austin, Austin, TX 78712, USA,Department of Nutritional Sciences, College of Natural Sciences, The University of Texas at Austin, Austin, TX 78712, USA,Department of Pediatrics, Dell Medical School, The University of Texas at Austin, Austin, TX 78712, USA,Interdisciplinary Life Sciences Graduate Programs (ILSGP), The University of Texas at Austin, Austin, TX 78712, USA
| | - Erxi Wu
- Livestrong Cancer Institutes, Department of Oncology, Dell Medical School, The University of Texas at Austin, Austin, TX 78712, USA,Neuroscience Institute and Department of Neurosurgery, Baylor Scott & White Health, Temple, TX 76502, USA,Department of Surgery, Texas A & M University Health Science Center, College of Medicine, Temple, TX 76508, USA,Department of Pharmaceutical Sciences, Texas A & M University Health Science Center, College of Pharmacy, College Station, TX 77843, USA,Corresponding Authors: S. Stephen Yi, The University of Texas at Austin, 1601 Trinity St, Austin, TX 78712. Phone: 512-495-5245; , Nidhi Sahni, The University of Texas MD Anderson Cancer Center, 1881 East Rd, Houston, TX 77054. Phone: 512-237-9506; , Jason H. Huang, Baylor Research Institute, 5701 Airport Road, Temple, TX 76502. Phone: 254-724-2475; , Erxi Wu, Baylor Research Institute, 5701 Airport Road, Temple, TX 76502. Phone: 254-724-3785;
| | - Jason H. Huang
- Neuroscience Institute and Department of Neurosurgery, Baylor Scott & White Health, Temple, TX 76502, USA,Department of Surgery, Texas A & M University Health Science Center, College of Medicine, Temple, TX 76508, USA,Corresponding Authors: S. Stephen Yi, The University of Texas at Austin, 1601 Trinity St, Austin, TX 78712. Phone: 512-495-5245; , Nidhi Sahni, The University of Texas MD Anderson Cancer Center, 1881 East Rd, Houston, TX 77054. Phone: 512-237-9506; , Jason H. Huang, Baylor Research Institute, 5701 Airport Road, Temple, TX 76502. Phone: 254-724-2475; , Erxi Wu, Baylor Research Institute, 5701 Airport Road, Temple, TX 76502. Phone: 254-724-3785;
| | - Nidhi Sahni
- Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX 77054, USA,Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA,Quantitative and Computational Biosciences Program, Baylor College of Medicine, Houston, TX 77030, USA,Corresponding Authors: S. Stephen Yi, The University of Texas at Austin, 1601 Trinity St, Austin, TX 78712. Phone: 512-495-5245; , Nidhi Sahni, The University of Texas MD Anderson Cancer Center, 1881 East Rd, Houston, TX 77054. Phone: 512-237-9506; , Jason H. Huang, Baylor Research Institute, 5701 Airport Road, Temple, TX 76502. Phone: 254-724-2475; , Erxi Wu, Baylor Research Institute, 5701 Airport Road, Temple, TX 76502. Phone: 254-724-3785;
| | - S. Stephen Yi
- Livestrong Cancer Institutes, Department of Oncology, Dell Medical School, The University of Texas at Austin, Austin, TX 78712, USA,Interdisciplinary Life Sciences Graduate Programs (ILSGP), The University of Texas at Austin, Austin, TX 78712, USA,Oden Institute for Computational Engineering and Sciences (ICES), The University of Texas at Austin, Austin, TX 78712, USA,Department of Biomedical Engineering, Cockrell School of Engineering, The University of Texas at Austin, Austin, TX 78712, USA,Corresponding Authors: S. Stephen Yi, The University of Texas at Austin, 1601 Trinity St, Austin, TX 78712. Phone: 512-495-5245; , Nidhi Sahni, The University of Texas MD Anderson Cancer Center, 1881 East Rd, Houston, TX 77054. Phone: 512-237-9506; , Jason H. Huang, Baylor Research Institute, 5701 Airport Road, Temple, TX 76502. Phone: 254-724-2475; , Erxi Wu, Baylor Research Institute, 5701 Airport Road, Temple, TX 76502. Phone: 254-724-3785;
| |
Collapse
|